Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Calgary
$105,000.00
Investigation into the Viridans Group Streptococci within Adult Cystic Fibrosis Patients
FY 2011-12
Summary
Cystic fibrosis (CF) is a genetic disease that affects over 4,000 Canadians with 1 of every 25 healthy people carrying the diseased gene. The disease results in thick mucus building up in the lower lungs, an area that is otherwise free of bacteria in healthy individuals, but results in long-term infections for people with CF. The average age for people with CF is 46.7 with no cure to date. Despite the fact that CF is caused by a mutated gene, 90% of people die as a result of these chronic bacterial infections. Traditionally, only specific bacteria have been studied but recently it has been shown that otherwise ignored bacteria are playing a role in CF disease progression. These bacteria come from the group of bacteria known as streptococci. The streptococci are carried in healthy individuals in the upper respiratory tract and are thought not to normally cause disease. However, it is our hypothesis, based upon recent studies, that these streptococci are contributing to CF disease progression. One idea is they may be causing disease by acting as pathogens, such as is the case with the streptococci that cause strep throat or flesh-eating disease. Another theory is that they are contributing to antibiotic resistance seen in CF patients, as the streptococci can easily become resistant to drugs such as penicillin. The final idea is that the streptococci are interacting with other bacteria in the CF lung to make the pathogens even more virulent or dangerous. One of these bacteria, Pseudomonas aeruginosa, is well-known to cause infections in CF patients and some recent studies have shown certain streptococci make P. aeruginosa even more pathogenic than if it were alone, otherwise known as a virulent synergistic relationship. By studying the role of the streptococci, which are extremely abundant in the CF lung, we can better understand disease progression and target therapy towards appropriate microbes.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
257425
Name
Eshaghurshan Christina S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigation into the Viridans Group Streptococci within Adult Cystic Fibrosis Patients
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Bacterial Pathogenesis; Cystic Fibrosis; Microbiology; Pseudomonas Aeruginosa; Streptococci; Synergens; Transposon Mutagenesis; Virulence
Abstract
Cystic fibrosis (CF) is a genetic disease that affects over 4,000 Canadians with 1 of every 25 healthy people carrying the diseased gene. The disease results in thick mucus building up in the lower lungs, an area that is otherwise free of bacteria in healthy individuals, but results in long-term infections for people with CF. The average age for people with CF is 46.7 with no cure to date. Despite the fact that CF is caused by a mutated gene, 90% of people die as a result of these chronic bacterial infections. Traditionally, only specific bacteria have been studied but recently it has been shown that otherwise ignored bacteria are playing a role in CF disease progression. These bacteria come from the group of bacteria known as streptococci. The streptococci are carried in healthy individuals in the upper respiratory tract and are thought not to normally cause disease. However, it is our hypothesis, based upon recent studies, that these streptococci are contributing to CF disease progression. One idea is they may be causing disease by acting as pathogens, such as is the case with the streptococci that cause strep throat or flesh-eating disease. Another theory is that they are contributing to antibiotic resistance seen in CF patients, as the streptococci can easily become resistant to drugs such as penicillin. The final idea is that the streptococci are interacting with other bacteria in the CF lung to make the pathogens even more virulent or dangerous. One of these bacteria, Pseudomonas aeruginosa, is well-known to cause infections in CF patients and some recent studies have shown certain streptococci make P. aeruginosa even more pathogenic than if it were alone, otherwise known as a virulent synergistic relationship. By studying the role of the streptococci, which are extremely abundant in the CF lung, we can better understand disease progression and target therapy towards appropriate microbes.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Eshaghurshan, Christina S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~